| Cost-effectiveness analysis of semaglutide 2.4 mg for the treatment of adult patients with overweight and obesity in the United States N Kim, J Wang, C Burudpakdee, Y Song, A Ramasamy, Y Xie, R Sun, ... Journal of Managed Care & Specialty Pharmacy 28 (7), 740-752, 2022 | 42 | 2022 |
| Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine MT Driessen, JM Cohen, SF Thompson, O Patterson-Lomba, ... The Journal of Headache and Pain 23 (1), 56, 2022 | 39 | 2022 |
| Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart study MT Driessen, JM Cohen, O Patterson-Lomba, SF Thompson, M Seminerio, ... The Journal of Headache and Pain 23 (1), 47, 2022 | 16 | 2022 |
| Benefit–Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis P Conaghan, S Cohen, G Burmester, E Mysler, P Nash, Y Tanaka, ... Rheumatology and Therapy, 1-16, 2021 | 5 | 2021 |
| Real-world Reductions in Monthly Migraine Days and Migraine-Related Healthcare Resource Utilization in UK Patients Using Fremanezumab S Afridi, TI Totev, LJ Krasenbaum, E Terasawa, H Akcicek, D Dhiraj, ... CEPHALALGIA 42 (1_ SUPPL), 74-75, 2022 | 2 | 2022 |
| Abstract 6 Projected impact of omidubicel on racial and ethnic disparities in allogeneic hematopoietic cell transplant access and outcomes for patients with hematologic … U Gergis, N Khera, ML Edwards, Y Song, R Sun, R Simantov, ... Stem Cells Translational Medicine 11 (Supplement_1), S8-S8, 2022 | 2 | 2022 |
| Real-world reductions in migraine and headache days for patients with migraine initiating fremanezumab in Germany A Heinze, T Totev, L Krasenbaum, E Terasawa, H Akcicek, J Hipp, R Sun, ... EUROPEAN JOURNAL OF NEUROLOGY 29, 419-419, 2022 | 2 | 2022 |
| Superior Outcomes With Continuing Tenofovir Versus Switching to Zidovudine in Second-Line Antiretroviral Therapy in Haiti S Pierre, I Bocharova, C Nguyen, F Homeus, G Julmiste, Y Macius, ... Open Forum Infectious Diseases 8 (12), ofab559, 2021 | 2 | 2021 |
| Projected impact of omidubicel-onlv on racial/ethnic disparities in allogeneic hematopoietic cell transplantation (Allo-HCT) outcomes in hematologic malignancies N Khera, ML Edwards, Y Song, R Sun, R Manghani, H Shin, R Simantov, ... Advances in Therapy 41 (4), 1637-1651, 2024 | 1 | 2024 |
| EE121 Numbers Needed to Treat and Costs per Improved Outcome Among Treatments for Myasthenia Gravis C Qi, J Wang, H Yang, D Gelinas, E Brauer, M Du, R Sun, G Phillips Value in Health 25 (7), S358, 2022 | 1 | 2022 |
| POSB26 Real-World Effectiveness of Fremanezumab Treatment for Reducing Monthly Migraine and Headache Days in US Patients Having Different Numbers of PRIOR Migraine Preventive … J Cohen, S Thompson, R Sun, M Driessen, M Seminerio, K Carr, F Mu Value in Health 25 (1), S30, 2022 | 1 | 2022 |
| Beyond Parochial Altruism: Shared Crises and Cross-Ethnic Solidarities in Lebanon M Cammett, A Rizkallah, R Sun | | 2024 |
| Carbon Copy: US Public Opinion on the Diffusion of Carbon Border Adjustment Mechanisms T Ingles, R Sun, D Tingley | | 2024 |
| Continuity of care during severe civil unrest with a model of community-based HIV care: a retrospective cohort study from Haiti P Joseph, R Sun, C Guiteau, MAJ Juste, N Dorvil, S Vilbrun, R Secours, ... The Lancet Regional Health–Americas 37, 2024 | | 2024 |
| Correction to: Projected Impact of Omidubicel-onlv on Racial/Ethnic Disparities in Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Outcomes in Hematologic Malignancies … N Khera, ML Edwards, Y Song, R Sun, R Manghani, H Shin, R Simantov, ... Advances in Therapy, 2024 | | 2024 |
| Numbers Needed to Treat and Costs Per Improved Outcome Among Treatments for Myasthenia Gravis T Hughes, C Qi, J Wang, H Yang, D Gelinas, E Brauer, M Du, R Sun, ... Neurology 99 (23_Supplement_2), S38-S39, 2022 | | 2022 |
| RISK BENEFIT ANALYSIS OF TREATMENTS FOR PATIENTS WITH MYASTHENIA GRAVIS C Qi, T Hughes, J Wang, H Yang, D Gelinas, AG Smith, A Habib, E Brauer, ... MUSCLE & NERVE 66, S135-S135, 2022 | | 2022 |
| Maintaining patient care in the context of major and prolonged socio-political turmoil in Haiti through community care centers for antiretroviral therapy distribution and viral … P Joseph, R Sun, JE Mathon, Y Macius, MA Juste, C Guiteau, S Koenig, ... JOURNAL OF THE INTERNATIONAL AIDS SOCIETY 25, 254-254, 2022 | | 2022 |
| Real-world Reductions in Migraine-related Healthcare Resource Utilization for German Patients Initiating Fremanezumab A Heinze, T Totev, L Krasenbaum, E Terasawa, H Akcicek, J Hipp, R Sun, ... EUROPEAN JOURNAL OF NEUROLOGY 29, 420-420, 2022 | | 2022 |
| Projected Impact of Omidubicel on Racial and Ethnic Disparities in Allogeneic Hematopoietic Cell Transplant Access and Outcomes for Patients with Hematologic Malignancies in the US U Gergis, N Khera, ML Edwards, Y Song, R Sun, R Simantov, ... Transplantation and Cellular Therapy, Official Publication of the American …, 2022 | | 2022 |
